Illinois adult-use cannabis sales climbed 5.6% in December to $116.6 million, marking a sequential gain after months of data delays. The state released figures for November and December on Friday, following a major historical revision in its prior update. This release highlights persistent challenges in tracking sales accurately since the shift to new software.
Sequential Uptick Contrasts Steeper Yearly Drop
December sales reached $116.6 million, up from November on both a total and per-day basis, with daily growth at 2.2%. Year-over-year, however, the figure fell 23.9%, a marginal improvement from November's 26.1% decline. The state's transition to Metrc, a seed-to-sale tracking system, caused earlier delays; officials noted in November that it now captures actual sales including discounts, correcting prior overstatements from pre-discount prices.
2025 Marks First Annual Contraction Since Launch
Adult-use sales grew rapidly after legalization: 106% in 2021, 13% in 2022, and 5% in 2023. Year-to-date 2024 totals hit $1.72 billion, a 5.4% increase. In 2025, sales dropped 12.5% to $1.51 billion, falling below 2022 levels and signaling market saturation in the nation's second-largest cannabis economy.
Medical Program Lags Without Fresh Data
No new medical cannabis figures have emerged since April, when sales dipped 1.6% sequentially to $19.7 million, down 13.2% year-over-year. Illinois tracks medical and adult-use programs separately, reflecting distinct regulatory paths. The lack of updates underscores ongoing integration issues with Metrc, which aims to enhance compliance and precision across both sectors.
Tracking Upgrade Reshapes Data Reliability
Past reports inflated figures by using pre-discount prices, a flaw Metrc addresses through checkout-level reporting. This revision through October, paired with the new two-month data, offers a cleaner historical view. For industry stakeholders, the dip reflects maturing competition and consumer shifts, while improved tracking could inform future tax policies and supply chain decisions in a market that launched recreational sales in 2020.
